AIMC Topic: Peptide Fragments

Clear Filters Showing 1 to 10 of 75 articles

SARS-CoV-2 peptide fragments selectively dysregulate specific immune cell populations via Gaussian curvature targeting.

Proceedings of the National Academy of Sciences of the United States of America
Immune cell populations are dysregulated in COVID-19 for currently unknown reasons: Plasmacytoid dendritic cell (pDC) populations are reduced, thus hampering antiviral responses. CD8 T cell populations are reduced, the level of which has emerged as a...

The relationship between amyloid-β peptide spectrum and the spastic paraparesis phenotype in autosomal dominant Alzheimer's disease.

Alzheimer's research & therapy
BACKGROUND: More than 300 mutations in presenilin 1 (PSEN1) lead to autosomal dominant Alzheimer's disease (ADAD). PSEN1, as the catalytic subunit of γ-secretase, generates amyloid-β (Aβ) peptides through a sequential proteolysis of the amyloid precu...

Robust detection of femtogram-level Alzheimer's biomarkers using machine learning-enhanced graphene biosensors.

Biosensors & bioelectronics
Early diagnosis of Alzheimer's disease (AD) requires blood biomarker tests sensitive to femtogram/mL concentrations. Graphene field-effect transistors (GFETs) are promising for this application, but suffer from device-to-device variability and requir...

Employing deep mutational scanning in the periplasm to decode the thermodynamic landscape for amyloid formation.

Proceedings of the National Academy of Sciences of the United States of America
Deep mutational scanning (DMS) assays provide a powerful method to generate large-scale datasets essential for advancing AI-driven predictions in biology. The tripartite β-lactamase assay (TPBLA), in which a protein of interest is inserted between tw...

Optimizing timing and cost-effective use of plasma biomarkers in Alzheimer's disease.

Alzheimer's research & therapy
BACKGROUND AND OBJECTIVES: Early and cost-effective identification of amyloid positivity is crucial for Alzheimer's disease (AD) diagnosis. While amyloid PET is the gold standard, plasma biomarkers such as phosphorylated tau 217 (pTau217) provide a p...

Biomarker panels for improved risk prediction and enhanced biological insights in patients with atrial fibrillation.

Nature communications
Atrial fibrillation (AF) increases the risk of adverse cardiovascular events, yet the underlying biological mechanisms remain unclear. We evaluate a panel of 12 circulating biomarkers representing diverse pathophysiological pathways in 3817 AF patien...

Deep Learning for Cardiac Overload Estimation - Predicting B-Type Natriuretic Peptide (BNP) Levels From Heart Sounds and Electrocardiogram.

Circulation journal : official journal of the Japanese Circulation Society
BACKGROUND: B-type natriuretic peptide (BNP) and N-terminal pro-BNP (NT-pro-BNP) are key biomarkers used for heart failure (HF) management. Although traditional auscultation lacks objective evaluation, the SSS01-series phonocardiogram enables rapid r...

Massively parallel genetic perturbation suggests the energetic structure of an amyloid-β transition state.

Science advances
Amyloid aggregates are pathological hallmarks of many human diseases, but how soluble proteins nucleate to form amyloids is poorly understood. Here, we use combinatorial mutagenesis, a kinetic selection assay, and machine learning to massively pertur...

Diagnostic MicroRNA Signatures to Support Classification of Pulmonary Hypertension.

Circulation. Genomic and precision medicine
BACKGROUND: Patients with pulmonary hypertension (PH) are classified based on disease pathogenesis and hemodynamic drivers. Classification informs treatment. The heart failure biomarker NT-proBNP (N-terminal pro-B-type natriuretic peptide) is used to...

Machine learning integration of multimodal data identifies key features of circulating NT-proBNP in people without cardiovascular diseases.

Scientific reports
N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) is important for diagnosing and predicting heart failure or many other diseases. However, few studies have comprehensively assessed the factors correlated with NT-proBNP levels in people with cardi...